{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:22:49Z","timestamp":1760059369734,"version":"build-2065373602"},"reference-count":31,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Due to the rare focus on ureteral cancer survival analyses, this study investigates post-surgery cancer-specific survival (CSS) rates, along with prognostic factors affecting these outcomes. It aims to enhance understanding of disease progression and determinants of patient survival and develop a nomogram for reference. Materials and Methods: This research undertook a retrospective analysis of ureteral cancer patients who received surgical intervention from 2010 to 2017, utilizing data from the Surveillance, Epidemiology, and End Results database. The primary endpoint was survival, with 1-, 3-, and 5-year CSS rates calculated using the Kaplan\u2013Meier method. Initial univariate Cox proportional hazards analyses identified factors impacting survival, with those yielding a p-value under 0.05 progressing to multivariate Cox regression analysis to ascertain significant prognostic indicators. Results: The investigation encompassed 2277 patients diagnosed with ureteral cancer. CSS rates at 1, 3, and 5 years post-surgery were observed at 88.2%, 68.1%, and 60.3%, respectively. Multivariate analyses identified age, staging of tumor, node and metastasis, and the application of radiotherapy as significant prognostic indicators for CSS. Based on these factors, a post-surgical nomogram for CSS was developed. Conclusions: The survival outcomes for ureteral cancer are not yet satisfactory. Age and stage emerge as pivotal prognostic elements, significantly impacting CSS following surgery. Recognizing these factors is essential for clinicians, as they offer critical insights that inform treatment strategies and patient management.<\/jats:p>","DOI":"10.3390\/medicina61061062","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:42:25Z","timestamp":1749530545000},"page":"1062","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Nomogram to Predict Cancer-Specific Survival of Transitional Cell Carcinoma of Ureter After Surgery"],"prefix":"10.3390","volume":"61","author":[{"given":"Der-Shin","family":"Ke","sequence":"first","affiliation":[{"name":"Department of Neurology, China Medical University Beigang Hospital, Beigang, Yunlin 651012, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Yu","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chia-Yi 600566, Taiwan"},{"name":"Department of Artificial Intelligence and Healthcare Management, Central Taiwan University of Science and Technology, Taichung 406053, Taiwan"},{"name":"Department of General Education, National Chin-Yi University of Technology, Taichung 411030, Taiwan"},{"name":"Department of Senior Citizen Service Management, National Taichung University of Science and Technology, Taichung 404336, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/00365599309180442","article-title":"Trends in the incidence of cancer of the kidney, pelvis, ureter and bladder in Denmark 1943\u201388","volume":"27","author":"Mellemgaard","year":"1993","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int."},{"key":"ref_3","first-page":"607","article-title":"Trends of incidence and prognosis of upper tract urothelial carcinoma","volume":"21","author":"Wu","year":"2021","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102573","DOI":"10.1016\/j.fjurol.2024.102573","article-title":"Recent trends in incidence, mortality, survival, and treatment of upper tract urothelial carcinoma","volume":"34","author":"Ma","year":"2024","journal-title":"Fr. J. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Soualhi, A., Rammant, E., George, G., Russell, B., Enting, D., Nair, R., Van Hemelrijck, M., and Bosco, C. (2021). The incidence and prevalence of upper tract urothelial carcinoma: A systematic review. BMC Urol., 21.","DOI":"10.1186\/s12894-021-00876-7"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1464-410X.2008.07985.x","article-title":"Transitional cell carcinomas of the renal pelvis and the ureter: Comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population","volume":"103","author":"Tan","year":"2009","journal-title":"BJU Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/21681805.2013.795188","article-title":"A population-based study of tumours of the renal pelvis and ureter: Incidence, aetiology and histopathological findings","volume":"47","author":"Holmberg","year":"2013","journal-title":"Scand. J. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1464-410X.2007.06793.x","article-title":"Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia","volume":"99","author":"Dragicevic","year":"2007","journal-title":"BJU Int."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gao, J., Liu, J., Liu, J., Lin, S., and Ding, D. (2022). Survival and risk factors among upper tract urothelial carcinoma patients after radical nephroureterectomy in Northeast China. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1012292"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wu, H., Jia, D., Dai, X., Cao, H., Wang, F., Yang, T., Wang, L., Xu, T., and Gao, B. (2024). A new nomogram for predicting extraurothelial recurrence in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1442168"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"14241","DOI":"10.1007\/s00432-023-05237-5","article-title":"A novel nomogram for predicting extraurothelial recurrence in patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy","volume":"149","author":"Luo","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Tian, C., Liu, J., An, L., Hong, Y., and Xu, Q. (2023). Prognostic nomogram for overall survival in upper urinary tract urothelial carcinoma (UTUC) patients treated with chemotherapy: A SEER-based retrospective cohort study. BMC Urol., 23.","DOI":"10.1186\/s12894-022-01172-8"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/cncr.25122","article-title":"Highly predictive survival nomogram after upper urinary tract urothelial carcinoma","volume":"116","author":"Jeldres","year":"2010","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/bjc.2012.64","article-title":"Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: Proposal and multi-institutional validation of a post-operative nomogram","volume":"106","author":"Yates","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.eururo.2006.11.021","article-title":"Transitional cell carcinoma of the ureter: Prognostic factors influencing progression and survival","volume":"51","author":"Lehmann","year":"2007","journal-title":"Eur. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Xia, Y., Ma, B.B., Li, M.Y., Liu, X., Xu, D.F., and Huang, T. (2024). Prognostic evaluation of segmental ureterectomy combined with chemotherapy in high-grade non-metastatic ureteral cancer: A study based on the SEER database. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-77117-y"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"65983","DOI":"10.18632\/oncotarget.19623","article-title":"Prognostic factors and outcomes of primary transitional cell carcinoma of the ureter: A population-based study","volume":"8","author":"Ding","year":"2017","journal-title":"Oncotarget"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clgc.2023.08.001","article-title":"Advanced age impacts survival after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"22","author":"Ferro","year":"2024","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ye, J., Wu, Q., Liao, X., Zheng, L., Wei, Q., and Bao, Y. (2023). Advanced age may not be an absolute Contraindication for radical nephroureterectomy in patients with upper tract urothelial carcinoma: A single-center case series and a systematic review with meta-analyses. J. Clin. Med., 12.","DOI":"10.3390\/jcm12237273"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bju.15984","article-title":"Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy","volume":"132","author":"Claps","year":"2023","journal-title":"BJU Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/JU.0000000000001886","article-title":"Oncologic surveillance for variant histology bladder cancer after radical cystectomy","volume":"206","author":"Martini","year":"2021","journal-title":"J. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.urology.2007.03.051","article-title":"Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: Implications for therapy","volume":"70","author":"Brown","year":"2007","journal-title":"Urology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.urology.2009.07.1350","article-title":"Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma","volume":"75","author":"Kim","year":"2010","journal-title":"Urology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4.e19","DOI":"10.1016\/j.urolonc.2015.08.006","article-title":"The effect of tumor location on oncologic outcomes in patients with upper urinary tract urothelial carcinoma stratified by pathologic stage","volume":"34","author":"Tai","year":"2016","journal-title":"Urol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.euf.2017.09.015","article-title":"Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial urothelial carcinoma: A systematic review by the European Association of Urology guidelines panel on non-muscle-invasive bladder cancer","volume":"5","author":"Peyronnet","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Pandolfo, S.D., Cilio, S., Aveta, A., Wu, Z., Cerrato, C., Napolitano, L., Lasorsa, F., Lucarelli, G., Verze, P., and Siracusano, S. (2024). Upper tract urothelial cancer: Guideline of guidelines. Cancers, 16.","DOI":"10.3390\/cancers16061115"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/curroncol30010002","article-title":"Adjuvant radiotherapy for upper tract urothelial carcinoma: Systematic review and meta-analysis","volume":"30","author":"Zalay","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Chen, B., Zeng, Z.C., Wang, G.M., Zhang, L., Lin, Z.M., Sun, L.A., Zhu, T.Y., Wu, L.L., Zhang, J.Y., and Ji, Y. (2011). Radiotherapy may improve overall survival of patients with T3\/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse. BMC Cancer, 11.","DOI":"10.1186\/1471-2407-11-297"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"410.e1","DOI":"10.1016\/j.urolonc.2022.03.006","article-title":"Effectiveness of adjuvant radiotherapy for high recurrence risk patients with upper tract urothelial carcinoma","volume":"40","author":"Li","year":"2022","journal-title":"Urol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1089\/end.2021.0587","article-title":"Robotic vs laparoscopic nephroureterectomy for upper tract urothelial carcinoma: A multicenter propensity-score matched pair \u201ctetrafecta\u201d analysis (ROBUUST Collaborative Group)","volume":"36","author":"Veccia","year":"2022","journal-title":"J. Endourol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00345-023-04406-y","article-title":"Impact of smoking on urologic cancers: A snapshot of current evidence","volume":"41","author":"Kumar","year":"2023","journal-title":"World J. Urol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1062\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:49:04Z","timestamp":1760032144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["medicina61061062"],"URL":"https:\/\/doi.org\/10.3390\/medicina61061062","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,6,9]]}}}